 Telegraph.co.uk | Nobel winner Yamanaka's priority goal: 'iPS Stock' The Japan Times In the iPS Stock project, Yamanaka plans to derive the cell lines from people with a special white blood cell type that is far less likely to lead to transplant rejection. Yamanaka said cells from a single donor would produce enough iPS cells for about ... Nobel Prize for medicine awarded to Gurdon, Yamanaka for stem cell discoveries 2 win Nobel Prize in medicine for stem-cell discoveries |
